The Antiviral Drug Duovir For Systemic Use In The Treatment Of HIV Infection

(MENAFN- RCTT) The manufacturing enterprise "Akademfarm" offers consumers an antiviral drug "Duovir" for systemic use in the treatment of HIV infection under a manufacturing agreement and is looking for partners to conclude a distribution services agreement. Description The group of medications known as systemic antiviral agents for the treatment of HIV infection is internationally referred to as antiretroviral drugs (ARVs). The global market for these medications is clearly divided into two groups: developers of original, innovative regimens (US and Europe) and the largest manufacturers of affordable generics (India). These corporations control over 75% of global sales by value. They create innovative all-in-one pills and extended-release injectable formulations:
1. Gilead Sciences (US) is the absolute global leader (controlling the majority of the market). It produces bestsellers such as Biktarvy, Genvoya, Truvada, as well as the revolutionary subcutaneous drug Lenacapavir (Yeztugo).
2. ViiV Healthcare (UK) is a specialized company created by GlaxoSmithKline (GSK) and Pfizer. Known for its drugs Tivicay (dolutegravir), Triumeq, Dovato, and the first long-acting injectable solution, Cabenuva.
3. Merck & Co. / MSD (USA) - produces the popular drugs Isentress (raltegravir) and Pifeltro (doravirine). It is actively collaborating with Gilead on the development of next-generation combination regimens.
4. Janssen Pharmaceuticals (part of Johnson & Johnson, USA) - a key manufacturer of protease inhibitors and other ART components, including Prezista (darunavir) and Edurant (rilpivirine).
Indian companies produce the bulk of medications for low- and middle-income countries, supplying them under WHO and UNAIDS programs:
1. Cipla Limited - a pioneer in affordable therapy, supplying combination ARVs worldwide.
2. Hetero Drugs is the largest supplier of finished dosage forms and active pharmaceutical ingredients for the treatment of HIV.
Information about the drug "Duovir", produced by the Enterprise "Akadempharm" - an antiviral agent for systemic use in the treatment of HIV infection as part of combination antiretroviral therapy, is posted on the official website of the Enterprise here. Advantages and Innovations In-house production. Highly qualified personnel. Stage of development Already on the market Comments regarding stage of development International nonproprietary name: Lamivudine/Zidovudine.
Substance: India
* In other regions, packaging design may vary depending on the country of registration. Funding source State budged
Internal
IPR status Exclusive rights
Secret know-how
Sector group BioChemTech
Healthcare
Materials
Client information Type R&D institution Year established 2009 NACE keywords C.21.20 - Manufacture of pharmaceutical preparations
M.72.20 - Research and experimental development on social sciences and humanities
M.74.90 - Other professional, scientific and technical activities n.e.c.
Q.86.90 - Other human health activities
Turnover (in EUR) 10-20M Already engaged in transnational cooperation Yes Additional comments The Republican production unitary enterprise "ACADEMPHARM" is a dynamically developing, science-intensive state-owned pharmaceutical company. Despite its young age in the pharmaceutical industry, "ACADEMPHARM" has already carved out a niche in the domestic market and continues to expand. The company focuses on unmet medical needs, expanding its product range annually.
Activities:
- Laboratory pharmaceutical research;
- Industrial production of medicinal products and other pharmaceuticals, vitamins, vitamin-mineral and metabolic complexes, and nutraceuticals;
- Contract pharmaceutical manufacturing.
Production lines are equipped with the latest equipment from leading global companies, meeting all GMP requirements.
The pharmaceutical quality system includes good manufacturing practices, quality control, and quality risk management. It is fully documented, and its effectiveness is monitored. All components of the quality system are staffed with competent personnel, sufficient facilities, equipment, and technical resources.
Official website of the Enterprise "Academpharm". Certification standards The Republican production unitary enterprise "AKADEMPHARM" holds national GMP (Good Manufacturing Practice) certificates for the production of all forms of its own products.
The company has implemented and operates a pharmaceutical quality system developed in accordance with the requirements of the national standard TKP 030-2017 (33050) "Good Manufacturing Practice" and international requirements. Languages spoken English
Russian
Information about partnership Type of partnership considered Distribution services agreement
Manufacturing agreement
Type and role of partner sought Consumers interested in purchasing a dosage of the antiviral drug "Duovir" for systemic use in the treatment of HIV infection may differ depending on the country of registration under a manufacturing agreement.
Partners interested in purchasing a dosage of the antiviral drug "Duovir" for systemic use in the treatment of HIV infection may differ depending on the country of registration under a distribution services agreement. Type and size of partner sought > 500
251-500
SME 51-250
SME 11-50
SME <= 10
R&D Institution
University
Sole proprietor

MENAFN28082026008611018181ID1111592823